More importantly, the in vivo results disclosed that TREM2 inhibition visibly reduced the infiltration of Th2 and Treg cells and increased the infiltration of Th1 cells in GBM microenvironment (Fig. 7). The gene discussed is TREM2; the disease is glioblastoma.